Piper Jaffray upgrades Biosite Incorporated (BSTE) to Market Perform
More News related to BSTE
- Atticus Capital Boosts Stake in Inverness Medical (IMA) to 5.5%
- Piper Jaffray upgrades Biosite Incorporated (BSTE) to Market Perform
- Stifel Nicolaus Upgrades Inverness Medical Innovations (IMA) to Buy
- Largest $ Movers of Note - StreetInsider.com - 05/15/2007
- Inverness Medical Innovations (IMA) Raises Bid for Biosite (BSTE) to $92.50
More News related to IMA
- OraSure Tech (OSUR) Settles Patent Infringement Suit with Inverness (IMA), Inverness Switzerland, and Church & Dwight (CHD)
- OraSure Tech (OSUR) Settles Patent Infringement Suit with Inverness (IMA), Inverness Switzerland, and Church & Dwight (CHD)
- Alere Secures Prestigious NCQA Accreditation for Wellness & Health Promotion
- OraSure Technologies Announces Settlement of Patent Infringement Lawsuit With Inverness and Church & Dwight
- Triage Wireless, Inc. Becomes Sotera Wireless, Inc.
Piper Jaffray upgrades Biosite Incorporated (Nasdaq: BSTE) from Underperform to Market Perform and raises its price target to $92.50, citing increased level of confidence around the completion of the Inverness/Biosite acquisition.
Related Categories
UpgradesStocks Mentioned
-92.48Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
